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ing grafts at risk for developing stenoses.4,7-9 Operative
revision of threatened grafts is effective at maximizing
graft patency and limb-salvage rates. Although patency of
LEVGs has traditionally been reported at 5 years, most
patients who undergo vein graft revisions have been
shown to survive for longer periods. Additionally, the pop-
ulation is aging at a dramatic rate. The 1998 report from
the Bureau of Vital Statistics reported a record high aver-
age life expectancy of 76.7 years for Americans, with a
trend toward a continued increase.10
With the expectations for not only increasing survival,
but also a greater number of people reaching old age, it is
likely that LEVG procedures will increase in number. The
subset of patients undergoing revisions of LEVGs is one
that appears to have a relative survival advantage. Five-year
survival rates in patients undergoing revision of LEVGs is
as high as 80%.11 For these reasons, it is appropriate to dis-
cuss outcomes beyond 5 years after revascularization. An
analysis of the 10-year assisted primary patency, limb-
salvage, and survival rates in a cohort of patients undergo-
ing LEVG revisions forms the basis of this report.
It is now well established that approximately 20% of
lower-extremity vein grafts (LEVGs) will develop stenoses
within the graft or in the native arterial inflow or outflow
that threaten the patency of the graft.1-6 An aggressive
program of life-long duplex ultrasound scanning-based
graft surveillance is recommended as a means of identify-
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Purpose: Reversed lower-extremity vein grafts (LEVGs) frequently require operative revisions to maintain patency.
Identifying grafts that are at risk, however, requires an intensive duplex scanning-based surveillance program. Excellent
5-year graft patency and limb-salvage rates have previously been reported in patients undergoing graft revisions, but
results beyond 5 years are essentially unknown, a factor that is of importance in an increasingly aging population. This
study was performed to determine the results of surgical revisions of LEVGs after a follow-up as long as 10 years.
Methods: All patients undergoing placement of a LEVG were observed in a program of duplex scanning-based surveil-
lance as long as the patient remained a candidate for graft revision. Grafts were considered for revision on the basis of
the presence of focal areas of increased velocity, a prestenotic to intrastenotic velocity ratio more than 3.0, or uniformly
low velocities throughout the graft. All lesions were confirmed with preoperative arteriography before revision.
Assisted primary patency, limb-salvage, and survival rates were determined by means of Kaplan-Meier analysis in all
patients who underwent LEVG revision from January 1990 to December 2000.
Results: A total of 1498 LEVG procedures were performed during the study period. A total of 330 surgical graft revi-
sions were performed on 259 extremities in 245 patients. The median follow-up period was 38 months. The assisted
primary patency rate of all grafts, the limb-salvage rate for patients undergoing surgery for limb-salvage indications,
and the survival rate of all patients were 87.4%, 88.7%, and 72.4%, respectively, 5 years after the original bypass graft-
ing procedure, 85.7%, 83.4%, and 67.8%, respectively, 7 years after the original bypass grafting procedure, and 80.4%,
75.4%, and 53.4%, respectively, 10 years after the original bypass grafting procedure. A total of 180 revisions (55%)
were performed during the first year, 110 (33%) between the first year and the fifth year, and 40 revisions (12%) were
performed on grafts older than 5 years. LEVGs revised within the first year after bypass grafting had lesions within the
graft in 78%, in the native arterial inflow in 10%, and in the native arterial outflow in 12%. This differed significantly
from the location of lesions in revisions performed between 1 and 5 years and after 5 years (graft, 63% and 62%; inflow,
20% and 19%; outflow, 17% and 19%; P > .05, Chi-square).
Conclusion: Excellent assisted primary patency and limb-salvage rates can be achieved for as long as 10 years in LEVGs
that require revision, with only a 7% drop in overall patency and limb-salvage rates between the fifth and 10th years.
Although most revisions were required within the first year, 34% were performed between the first year and the fifth
year, and 11% after 5 years. These data support the growing body of evidence that favors an aggressive regimen of
duplex scanning surveillance of LEVGs for the life of the graft. Revised grafts have excellent patency through 10 years.
(J Vasc Surg 2002;35:56-63.)
METHODS
From Jan 1, 1990, to Dec 31, 2000, 1498 LEVG pro-
cedures were performed at the Oregon Health Sciences
University and Portland Veteran’s Administration Medical
Center. All patients were prospectively entered into a
postoperative duplex ultrasound scanning-based vein graft
surveillance protocol that included history and physical
examination, ankle/brachial index (ABI) determination,
and duplex scanning examination of the entire graft,
including the native inflow and outflow vessels. Patients
were examined during their initial hospitalization, every 3
months for the first year after the initial bypass grafting or
revision procedure, and every 6 months thereafter. Duplex
scanning examinations were performed by certified vascu-
lar technologists.
Criteria for identifying a graft that was at risk included
a focal peak systolic velocity (PSV) within the graft or in
the inflow or outflow sites greater than 200 cm/s, a
prestenotic to intrastenotic PSV ratio greater than 3.0, uni-
formly low PSV less than 45 cm/s throughout the entire
graft, an interval decrease in the ABI greater than 0.2, and
a significant change in clinical status. Arteriography was
performed on all patients who we believed were surgical
candidates before vein graft revision.
All lesions with greater than 50% diameter stenosis
identified by means of arteriogram were repaired. The revi-
sions were performed as soon as possible after the identifi-
cation of a suspicious lesion. Several types of revisions were
performed, depending on the nature and location of the
lesion(s). Interposition vein grafts involved placement of a
new vein segment within a graft and not involving the
proximal or distal anastomoses. Proximal revisions and dis-
tal extensions involved the creation of a new anastomosis
to the native arterial inflow or outflow with a new vein seg-
ment. Vein patch angioplasty involved placement of a vein
patch over a focal stenosis rather than placement of a new
segment of vein. Infrequently performed revision proce-
dures included resection of the stenotic lesion with primary
reanastomosis of the graft and release of externally com-
pressing fascial bands. Angioplasty was performed infre-
quently in patients who were not believed to be good
operative candidates. Inflow procedures (eg, iliac angio-
plasty with or without stenting, femoral artery interposi-
tion grafts, and extra-anatomic bypass grafting procedures)
were occasionally believed to be necessary as part of the
graft revision.
Patient data, including demographic data, the date,
conduit, inflow and outflow, indication for the initial oper-
ation, duplex surveillance data, and date, conduit, lesion
sites, and procedure performed for revision procedures,
were entered into a confidential computerized data base
(Corel Paradox, version 8.0, Borland International, Scotts
Valley, Calif). Dates of limb loss and death were also
recorded. The Kaplan-Meier method with log-rank analy-
sis was used as a means of estimating assisted primary
patency, limb-salvage, and survival rates. Statistical analysis
was performed with the chi-square test for frequencies and
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proportions and the t distribution for comparison of
means (JMP, version 3.1.5., SAS Institute, Cary, NC).
RESULTS
Patient demographics. The demographic informa-
tion on the 245 patients who underwent LEVG revision
are listed in Table I. Patients were predominantly men
(69%) with a history of hypertension (80%) and sympto-
matic coronary artery disease (54%). More than 90% of
patients had either a current or earlier history of smoking.
Forty-one percent of patients were undergoing treatment
for diabetes mellitus. Only 30% of patients had a history of
cerebrovascular disease, and 32% of patients had hyper-
cholesterolemia, although this information was frequently
obtained by means of patient history only and was not
specifically tested in all patients. Nine percent of patients
had a history of renal failure that required at least tempo-
rary dialysis.
More than half of the patients (54%) had undergone at
least one earlier lower-extremity vascular surgical proce-
dure, the most frequent of which were ipsilateral leg
bypass grafting procedures (24%), contralateral leg bypass
grafting procedures (21%), and aortobifemoral bypass
grafting procedures (15%). During the study period, 62
patients (25%) were lost to follow-up.
Characteristics of the original grafts. A total of 259
LEVGs were revised in 245 patients. Two hundred thirty-
one patients had a graft revised in one leg, and 14 patients
had grafts revised in both legs. The characteristics of the
original grafts are listed in Table II. More than 90% of
revised grafts were to an infrageniculate target. The most
Table I. Demographic information of 246 patients
undergoing lower-extremity bypass graft revision
Age at original operation (years) 66.9 ± 11.1














Earlier lower-extremity bypass grafting procedures 53%
Type of earlier lower-extremity bypass 
grafting procedures
Ipsilateral leg graft 24%
Contralateral leg graft 21%
Aortofemoral graft 15%
Axillofemoral or femorofemoral graft 5%
Femoral or iliac angioplasty/stent 4%
Femoral endarterectomy or interposition graft 3%
Contralateral leg amputation 2%
frequent graft undergoing revision was a femoral-tibial
graft (46.7%), and femoral–below-knee popliteal grafts
were the second most frequent graft undergoing revision
(40.2%). The common femoral artery was the most fre-
quent inflow vessel (46.7%); however, more than half of
the grafts arose distal to the common femoral artery from
the superficial femoral (25.9%), profunda femoral (25.1%),
or popliteal artery (2.3%). The saphenous vein, either ipsi-
lateral or contralateral, was the original conduit in approx-
imately 77% of grafts. Twenty-three percent of grafting
procedures were performed with an alternate conduit,
either a single-arm vein or composite arm/leg vein.
Seventy-five percent of grafting procedures were per-
formed for limb salvage (rest pain, ischemic ulcers, gan-
grene), whereas 24% were performed for lifestyle-limiting
claudication. The mean follow-up period for the grafts was
49 ± 42 months (mean ± SD; range, 1-204 months), with
a median follow-up period of 38 months.
Graft revisions. A total of 330 revision procedures
were performed in 259 LEVGs. The interval between the
identification of a lesion by means of duplex scanning and
the graft revision was less than 1 month in 95% of revi-
sions. A total of 204 grafts underwent a single revision
procedure, 42 grafts were revised twice, 10 grafts were
revised three times, and three grafts underwent four revi-
sions. A total of 288 revisions (87%) were performed on
the basis of a duplex scanning surveillance abnormality,
246 of which (75%) were caused by a focal area of
increased flow velocity and 42 of which (13%) were caused
by uniformly low flow velocities throughout the graft. A
total of 279 revisions performed on the basis of abnor-
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malities discovered by means of duplex scanning were not
associated with clinical symptoms, whereas only nine revi-
sions had concomitant clinical symptoms. Seventeen revi-
sions (5%) were prompted by an interval decrease in ABI,
and 25 revisions (8%) were prompted by worsening clini-
cal symptoms without an abnormality discovered by
means of duplex scanning. Therefore, 34 revisions (10%)
were also associated with clinical symptoms, whereas 90%
were asymptomatic.
The presence of symptoms was more frequent in grafts
that were revised between 5 and 10 years after the original
operation. Of 40 revisions performed between 5 and 10
years, 28 were prompted by asymptomatic duplex scanning
findings, three were prompted by duplex scanning abnor-
malities associated with worsening symptoms, eight were
prompted by worsening symptoms without duplex scan-
ning abnormalities, and one was prompted by a decrease in
ABI without duplex scanning abnormalities. Thus, 11 revi-
sions (28%) were associated with clinical symptoms, and 29
revisions (73%) were asymptomatic. In the 290 grafts
revised within the first 5 years, symptoms were present in
23 (8%), and 267 (92%) were asymptomatic (P < .001 in
comparison with grafts revised after 5 years).
The sites of revised lesions are listed in Table III. A
total of 440 lesions were repaired in the 330 revisions. The
most frequent site requiring revision was the proximal
portion of the graft, which was revised in 35% of the pro-
cedures. Progressively fewer stenoses were present in the
middle and distal portions of the grafts. Anastomotic
lesions were detected in 27% of revisions (18% proximal,
9% distal). A stenosis was present in the native arterial
inflow in 19% of revisions, and in the outflow vessel in 19%
of revisions.
The types of revision procedures performed are listed in
Table IV. A total of 392 procedures were performed during
the 330 revisions. An interposition vein segment was placed
from the graft to a more proximal native inflow site in 34%,
to a more distal native outflow site in 27%, and within the
graft in 26%. Vein patch angioplasty was performed in 21%
of revisions. An inflow procedure not involving the graft
(eg, iliac angioplasty/stent, femoral interposition graft) was
performed in addition to the graft revision in 7% of the revi-
sion procedures. Less frequently performed revision proce-
dures included excision of the stenotic portion of graft with
reanastomosis (2%), balloon angioplasty (2%), and release of
externally compressing tissue (1%).
Table II. Characteristics of 259 primary lower-extremity
bypass graft undergoing subsequent revision
Original type of bypass grafting procedure
Femoral-popliteal (above knee) 22 (8.5%)
Femoral-popliteal (below knee) 104 (40.2%)
Femoral-tibial 121 (46.7%)
Anterior tibial 44 (17.0%)





Common femoral artery 121 (46.7%)
Superficial femoral artery 67 (25.9%)
Profunda femoral artery 65 (25.1%)
Popliteal artery 6 (2.3%)
Original conduit
Ipsilateral greater saphenous vein 180 (69.5%)
Contralateral greater saphenous vein 21 (8.1%)
Single arm vein 17 (6.6%)
Composite arm or leg vein 40 (15.4%)
Lesser saphenous vein 2 (0.8%)
Original operative indication
Intermittent claudication 61 (23.6%)
Rest pain 94 (36.3%)
Ulcer/gangrene 101 (39.0%)
Popliteal aneurysm 2 (0.8%)
Cancer 1 (0.4%)
Table III. Sites of revised lesions in 330 lower-extremity
bypass graft revisions
Native arterial inflow 64 (19%)
Proximal anastomosis 59 (18%)
Proximal graft 115 (35%)
Mid-graft 63 (19%)
Distal graft 46 (14%)
Distal anastomosis 29 (9%)
Native arterial outflow 64 (19%)
The conduits used for vein graft revisions are listed in
Table V. The most frequently used conduit for revision
procedures was the basilic vein, which was used in 42% of
revisions. Other autogenous conduits used included the
cephalic vein (15%), the ipsilateral (19%) or contralateral
(13%) saphenous vein, the lesser saphenous vein (2%), the
femoral vein (1%), and the endarterectomized femoral
artery (0.3%). When no autogenous conduit was available
for the graft revision, prosthetic material (polyester or
polytetrafluoroethylene) was used (3%). In 5% of revisions,
the procedure was performed without the use of an addi-
tional conduit.
Timing of revisions. The mean time between the ini-
tial operation and revision was 23 ± 29 months (mean ±
SD), with a median time of revision of 11 months. A total
of 180 revisions (55%) were performed during the first
year after the original bypass grafting procedure. An addi-
tional 110 revisions (33%) were performed between the
first year and fifth year after the original bypass grafting
procedure. Forty revisions (12%) were performed more
than 5 years after the original bypass grafting procedure.
When grafts were revised within the first year, 78% of
lesions were within the graft, 10% involved the graft
inflow, and 12% involved the graft outflow (Table VI).
Grafts revised between 1 and 5 years and grafts revised
after 5 years also had lesions predominantly within the
graft (63% and 62%, respectively), but had a higher pro-
portion of inflow lesions (20% and 19%, respectively) and
outflow lesions (17% and 19%, respectively) than revisions
performed within the first year (P < .05, chi-square test).
Graft patency. Assisted primary patency for the 259
revised LEVGs is listed in Table VII. At 1, 3, 5, 7, 9, and
10 years, the assisted primary patency rates of revised
grafts were 95.7%, 90.6%, 87.4%, 85.7%, 83.5%, and
80.4%, respectively.
Limb salvage. Limb salvage for the 198 extremities
that underwent surgery for limb-salvage indications with
revised LEVG procedures is listed in Table VIII. Patients
whose initial operation was for claudication were
excluded. At 1, 3, 5, 7, 9, and 10 years, the limb-salvage
rates were 98.4%, 91.8%, 88.7%, 83.4%, 75.4%, and
75.4%, respectively.
Survival. Survival for the 245 patients undergoing
revision of a LEVG is listed in Table IX. The survival rates
at 1, 3, 5, 7, 9, and 10 years were 96.6%, 87.6%, 72.4%,
67.8%, 60.9%, and 53.4%, respectively.
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DISCUSSION
The importance of duplex graft surveillance as a means
of identifying stenoses of LEVGs has been established in
several independent reports. Revision has consistently
been found to be necessary in approximately 20% of
LEVGs, and multiple revisions are frequently required. In
this report, we have described the 10-year results of
revised LEVGs.
A total of 330 revision procedures were performed in
259 LEVGs from January 1990 to December 2000. The
patient demographic data are typical for a population of
patients undergoing vascular surgery, with a high inci-
dence of a history of smoking and concomitant cardiovas-
cular disease and diabetes mellitus. More than half of the
patients had undergone lower-extremity vascular surgical
procedures before the index LEVG that was subsequently
revised, which reflects our practice as a tertiary referral
center. Almost all bypass grafting procedures were to an
infrageniculate distal target, with bypass grafting proce-
dures to a tibial outflow vessel being most frequent. We
preferentially used the common femoral artery for inflow;
however, most LEVGs in this series originated distal to the
common femoral artery. This was frequently necessary
because of either the unsuitability of the common femoral
artery because of calcification or earlier operative proce-
dures or because of a lack of sufficient conduit length.
The long-term success of LEVG procedures is predi-
cated on an aggressive postoperative regimen of duplex
scanning-based graft surveillance. Our duplex criteria for
graft revision is deliberately liberal to maximize graft
patency. Optimal criteria for graft revision is a subject of
considerable debate. It is generally accepted that a peak
systolic velocity greater than 250 to 300 cm/s12-14 or a
systolic velocity ratio across a stenosis greater than 3.0 to
3.512-15 is highly predictive of a stenosis in excess of 70%
luminal diameter. In this study, all stenoses exceeding 50%
luminal diameter were repaired; thus, the reintervention
rate may be higher than in other studies. Additionally, we
relied on preoperative arteriography to plan the operative
procedure, correcting all identified lesions that exceed
50% luminal stenosis. Whereas other authors have advo-
cated arteriography only in selected cases,15-17 we showed
in an earlier study that additional lesions not detected by
means of duplex scanning are identified by means of pre-
procedural arteriography in as many as 20% of cases.1
Table IV. Types of revision procedures performed in
330 lower-extremity bypass graft revisions
Inflow procedure not involving graft 24 (7%)
Proximal revision 111 (34%)
Interposition 85 (26%)
Distal extension 88 (27%)
Vein patch angioplasty 69 (21%)
Excision/reanastomosis 6 (2%)
Balloon angioplasty 5 (2%)
Release of external compression 4 (1%)
Table V. Conduit used in 330 lower-extremity bypass
graft revisions
Basilic vein 137 (42%)
Cephalic vein 51 (15%)
Ipsilateral saphenous vein 63 (19%)
Contralateral saphenous vein 43 (13%)
Lesser saphenous vein 6 (2%)
Femoral vein 4 (1%)
Femoral artery 1 (0.3%)
Prosthetic 10 (3%)
None 16 (5%)
Because the LEVGs in this series were constructed
from reversed veins, lesions most frequently occurred in
the proximal portion of the graft. Although there is gen-
eral agreement that significant lesions detected within the
graft warrant revision, recent reports have questioned the
necessity of correcting proximal inflow18 and proximal
anastomotic19 lesions. Lesions at these sites were not
believed to negatively impact subsequent LEVG patency.
Although we continue to advocate revision of lesions at
these sites, this topic warrants further investigation.
The type of revision procedure performed in this series
depended on the nature and location of the lesion. Most
revisions involved placement of a new autogenous vein
segment, either within the original graft or to a new native
arterial inflow or outflow site. Vein patch angioplasty is
appropriate for focal stenoses within the graft. These are
frequently sites of valve hypertrophy or venovenostomy
sites of composite grafts. Longer stenoses (>2 cm), multi-
focal stenoses, or stenoses that involve progression of dis-
ease in the native arterial inflow or outflow are more
appropriately repaired with a new autogenous vein seg-
ment. The type of revision does not significantly impact
graft patency or need for subsequent revision, as we1,11
and other authors13,20 have shown in earlier studies. What
is important is that the revision procedure chosen is appro-
priate for the lesion being corrected.
The optimal revision conduit has likewise not been
fully established and is subject to the opinions of individ-
ual surgeons. We prefer to use arm veins because we have
typically found them to be an excellent quality conduit.
The use of arm veins is also well-suited to the two-team
approach that we favor, because one team can harvest the
vein while the other team prepares the revision targets.
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The use of the lesser saphenous vein harvest frequently
requires prone positioning and thus involves repositioning
the patient into a supine position for the revision proce-
dure. However, in the absence of suitable arm veins, we do
not hesitate to use additional autogenous conduit sources
to avoid using prosthetic conduit.
The 5-year assisted primary patency rate of revised
grafts was 88%, which is consistent with our earlier
reports.1,2,11 Other authors have reported excellent cumu-
lative patency results with aggressive operative revision of
LEVG, with 3-year to 5-year patency rates ranging from
70% to 80%.13,20-22 In contrast, unrevised LEVGs with
critical stenoses have a short-term rate of subsequent
occlusion that is as high as 80%.14 With continued graft
surveillance and revision of stenotic lesions, an assisted pri-
mary patency rate of 80% at 10 years in revised grafts was
achieved in this report. The limb-salvage rate at 10 years
was 84%. We remain surprised by these favorable results,
which exceed the patency rates of nonrevised grafts at our
institution.2,23 Grafts requiring multiple revisions perform
as well as those revised only once.11 It seems unlikely that
graft revision provides a protective benefit. Rather, what is
more likely is that some grafts are able to withstand the
temporary presence of a stenosis, and with regular surveil-
lance, these lesions can be detected and treated before
occlusion. The quality of the original graft conduit almost
certainly is an important factor in determining whether a
graft will remain patent in the presence of a critical steno-
sis. Idu et al, in a recently reported multivariate regression
analysis, found a graft diameter less than 3.5 cm to be the
only independent factor predicting the development of a
stenosis.24 The reason for graft failure remains an area of
continued research.
Table VI. Sites of revised lesions at different time intervals of revision after the initial bypass procedure
Site of lesions
Interval to revision Inflow Graft Outflow
0-1 year* 24 (10%) 185 (78%) 29 (12%)
1-5 years 29 (20%) 91 (63%) 24 (17%)
>5 years 11 (19%) 36 (62%) 11 (19%)
*P < .05 compared with grafts revised after the first year.
Table VII. Assisted primary patency of revised lower-extremity bypass grafts
Interval (months) Cumulative patency Interval patency SE Occluded Withdrawn At risk
0-6 0.9880 0.9880 0.0069 3 20 259
7-12 0.9573 0.9693 0.0132 7 29 236
13-24 0.9309 0.9736 0.0174 5 33 200
25-36 0.9058 0.9749 0.0942 4 30 162
36-48 0.8735 0.9677 0.0257 4 28 128
48-60 0.8735 1.0000 0.0257 0 24 96
61-84 0.8570 0.9835 0.0301 1 21 72
85-108 0.8345 0.9775 0.0368 1 20 50
109-120 0.8035 0.9690 0.0466 1 12 29
An additional topic of controversy is the necessary
duration of graft surveillance. This report concurs with
several studies that indicate that most stenoses occur
within the first year after bypass grafting.7,8,25 However,
Ihnat et al7 recommended life-long LEVG surveillance on
the basis of an annual 2% to 4% incidence of late-appear-
ing graft stenosis during long-term follow-up. Likewise, in
this report, approximately one-third of revisions were per-
formed between the first year and fifth year after bypass
grafting, and approximately 12% were performed after 5
years. While inflow and outflow lesions were proportion-
ally more frequent in grafts revised after 1 year, lesions
within the graft were most frequent at all time intervals.
Although symptomatic lesions were more frequent in
grafts revised more than 5 years after the original bypass
grafting procedure, asymptomatic lesions were most fre-
quent at all time intervals.
We, therefore, support the recommendations of sev-
eral groups4,7-9 for life-long graft surveillance as a means
of identifying these late-appearing graft-threatening
lesions. Our surveillance regimen includes duplex scan-
ning studies every 3 months for the first year and every 6
months thereafter. The frequency of duplex scanning
studies after 5 years is not well-established because of the
lack of available data on older grafts. Revisions are occa-
sionally required on grafts older than 5 years at sites that
were previously believed to be normal, indicating that
continued surveillance is an appropriate means of maxi-
mizing patency; however, further studies are needed to
establish the frequency of surveillance.
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The cost effectiveness of this approach needs to be
evaluated, especially in the current managed care environ-
ment. Although a cost analysis was not part of this study,
other studies have looked at the economic feasibility of
duplex scanning surveillance. Wixon et al26 demonstrated
that the costs of graft revision after occlusion and amputa-
tion far exceeded the costs of graft surveillance for as long
as 5 years, with revision when appropriate. This is a topic
that is certain to generate continued interest and will be
closely followed by third-party payers.
Missing from this study is functional outcome and
quality of life data on the examined patient cohort. LEVG
revisions are frequently seen as “minor” procedures when
compared with the initial “major” bypass grafting proce-
dure. However, as more operative procedures are per-
formed on older patients, the impact of even minor
operations on the patients’ subsequent quality of life can-
not be taken for granted. We and other authors have
shown that although ambulatory status and independent
living are maintained shortly after limb bypass grafting
surgery,27,28 long-term functional status is frequently sub-
optimal, and most patients undergoing infrainguinal
bypass grafting for limb salvage require continued or
repeated treatment for the remainder of their lives.29 The
functional outcome of patients undergoing LEVG proce-
dures and revisions remains an area of active interest and
research and an important topic from a public health
standpoint.
In summary, excellent long-term patency of LEVGs
can be achieved with the use of regular postoperative
Table IX. Survival in patients with a lower-extremity bypass graft undergoing revision
Interval (months) Cumulative survival Interval survival SE Dead Withdrawn At risk
0-6 0.9916 0.9916 0.0059 2 16 245
7-12 0.9644 0.9728 0.0124 6 24 227
13-24 0.9380 0.9736 0.0168 5 32 197
25-36 0.8756 0.9376 0.0247 10 23 160
37-48 0.8227 0.9471 0.0303 7 23 127
49-60 0.7242 0.9015 0.0386 11 15 97
61-84 0.6784 0.9542 0.0424 4 16 71
85-108 0.6089 0.9305 0.0505 4 18 51
109-120 0.5335 0.9246 0.0602 3 9 29
Table VIII. Limb salvage of 198 extremities with revised lower-extremity bypass grafts
Interval (months) Cumulative salvage Interval salvage SE Amputated Withdrawn At risk
0-6 0.9894 0.9894 0.0074 2 20 198
7-12 0.9836 0.9942 0.0094 1 30 176
13-24 0.9391 0.9555 0.0199 6 27 145
25-36 0.9293 0.9902 0.0220 1 27 112
37-48 0.9070 0.9777 0.0265 2 19 84
49-60 0.8869 0.9799 0.0327 1 19 63
61-84 0.8335 0.9466 0.0479 2 16 43
85-108 0.7537 0.9202 0.0690 2 9 25
109-120 0.7537 1.0000 0.0690 0 5 14
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duplex scanning follow-up and revision of stenotic lesions.
Although most revisions are required in the first year after
the initial bypass grafting procedure, 12% of the revisions
performed in this series were performed in grafts older
than 5 years. To our knowledge, this is the largest
reported series of revised LEVGs and the first to report
patency data for as long as 10 years.
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Dr Frank B. Pomposelli (Boston, Mass). Dr Landry and
his associates from OHSU are to be congratulated for adding
another important observation to their important list of con-
tributions on the results of lower-extremity arterial recon-
struction. Over a 10-year period they identified by both
duplex and arteriographic criteria 259 out of a total of
approximately 1500 grafts, or 17%, that they felt to be at risk
for graft thrombosis as part of a diligent graft surveillance
protocol. They revised these grafts at risk by a variety of meth-
ods and reported a remarkable 80.4% assisted patency and
83.8% limb salvage at 10 years—truly outstanding results and
the first such reported of which I am aware. Perhaps just as
remarkable is that slightly more than half of these patients
were still alive at 10 years.
I completely agree with the authors that these results confirm
the need for vascular surgeons to follow these patients for life and
underscore a fact of which we are well aware, that atherosclerosis
is incurable and that even the best lower-extremity bypass is
always at risk for failure due to progression of disease even many
years after successful implantation.
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I would also agree that aggressive intervention upon critical
stenoses is essential to prevent graft thrombosis and can result in
long-term continued patency as demonstrated so admirably in
their report. My concerns center on their definition of what is a
critical stenosis and are the basis of the following questions.
First, your duplex criteria for angiography are purposely
somewhat liberal to increase the sensitivity of your screening.
However, operating upon a 50% stenosis as demonstrated by arte-
riography, as outlined in the manuscript, seems liberal. Most
authors use 70%. I’m sure you’re aware that data have shown that
not all of these stenoses will progress to failure. Do you think
you’re being too liberal?
Second, 41% of your patient cohort had diabetes, but only
2.3% of grafts had inflow from the popliteal artery. In our prac-
tice, 60% do. If you combine this observation with the fact that
you correct all so-called inflow stenoses at the femoral level,
which has been suggested to be less critical in graft failure, even
less so in grafts arising from the popliteal, did your treatment
strategy and surveillance criteria cause you to intervene too early?
Dr Gregory J. Landry. I’d like to thank Dr Pomposelli for his
discussion, and he’s touched upon some very important questions
in terms of graft revision and graft surveillance.
I agree that our criteria for revision are liberal, but would point
out that it is not absolute. For example, if a graft has a focal steno-
sis with a peak systolic velocity in the range of 200 to 250, but the
systolic velocity ratio is low, less than 3, we may elect to follow that
patient. But certainly when the peak systolic velocity gets closer to
300, or the systolic velocity ratio exceeds 3, we would typically elect
to proceed at that point with revision. And when we obtain an arte-
riogram, the vast majority of the lesions seen are in the 70% or
greater range that most people would agree need to be fixed.
Nonetheless, while you’re correct in pointing out that very
few lesions in the 50% to 70% stenosis range occlude, it was
shown by Dr Mills and his group from Arizona last year at this
meeting that two thirds of these will progress to a greater than
70% stenosis. So in light of this, I still feel that it’s appropriate to
repair the lesions in the 50% to 70% range, particularly if you’re
repairing multiple lesions, which we found in at least one third of
the revision procedures that we performed.
With respect to diabetic patients, the vast majority of the
patients with diabetes in our patient group were elderly patients
with type 2 non–insulin-dependent diabetes. And these patients
typically have disease patterns which are seen in more typical ath-
erosclerotic patients. We also do manage patients with type 1
insulin-dependent diabetes, and these patients certainly do have
the disease pattern that you suggest. However, interestingly, very
few of these patients required revisions and therefore are not pres-
ent in this study. I’m not sure why they didn’t require revisions
and perhaps it has something to do with the shorter length of the
infrapopliteal grafts.
Several recent studies have suggested that inflow lesions do
not need to be revised. We too have been very impressed that
patients will present with significant inflow lesions but the graft
remains patent. In light of this, we frequently do not revise grafts
with isolated inflow lesions. However, if patients are presenting
for a revision of a lesion within the graft, and on preoperative
arteriography we identify a significant inflow lesion, we would fre-
quently repair both lesions at the time of the revision.
Dr John D. Corson (Iowa City, Iowa). Could you tell us a lit-
tle bit more about the 55 patients who had multiple revisions?
Were the multiple revisions at the same site or at different sites,
and what was the time interval between the specific revisions that
were done in those patients?
Of the revisions that were not proximal or distal but some-
where in the body of the vein conduit, how many were at veno-
venotomy sites? If it was not at a veno-venotomy site, what was
the reason for a lesion developing in the body of the conduit?
Dr Landry. We have found that in patients who undergo mul-
tiple revisions, lesions are at the site of a prior revision approxi-
mately 50% of the time and are at a new previously unrevised site
the other 50% of the time. The timing of those revisions is a bit
different. When the same site requires rerevision, the mean time
to that revision is about 10 months. If a new, previously unrevised
site requires revision, the time interval between prior revision and
secondary revision is approximately 20 months.
With respect to lesions within the graft, revisions at veno-
venostomy sites typically occurred within 1 year following the ini-
tial revision. About one quarter of the time a site of a
venovenostomy was a site of a subsequent revision. The majority
of new lesions within the graft are at a new site, typically at the
site of valve hypertrophy or at the site of recurrent atherosclero-
sis within the graft if they’re older lesions.
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